The risk depends on the failure to identify all germline mutations and the possibility of gonadal mosaicism in parents, both of which can be excluded if two somatic hits in RB1 are identified in tumor DNA and not in blood, thus leaving siblings with population risk only. This evidence concerns the gene RB1 and neoplasm.